Germany· DE-A57-6fdbc9d14d563c64
Sulpirid Stada
A sulpiride product containing sulpiride, registered in Germany by Stadapharm Gmbh. The same ATC class is registered in 12 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Sulpiride is registered in 12 of 19 countries.
Countries holding a registration under ATC N05AL01 (sulpiride), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 7 of them publish a price we can compare per daily dose
Sulpiride · ATC N05AL01
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of sulpiride costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), the median price runs from $1.00 in France to $3.83 in Switzerland — a ×3.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sulpiride · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.83
- FR France$1.00
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Sulpiride
- Manufacturer
- Stadapharm Gmbh
- Country
- Germany (DE)
- ATC code
- N05AL01
- ATC class
- Sulpiride
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
23 interactions on record for sulpiride.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sulpiride · interactions on record
23 records
23 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Sulpiride in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDolmatil 200mg tabletsSanofi
- CzechiaDOGMATILNeuraxpharm Bohemia s.r.o., Praha
- BelgiumDogmatil 0,5 mg/100 mlSanofi Belgium
- FranceDOGMATIL 0,5 g/100 ml SANS SUCRE, solution buvable édulcorée au cyclamate de sodiumNEURAXPHARM FRANCE
- PolandSulpiryd HascoPrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- SpainDOGMATIL 50 mg/ml SOLUCION INYECTABLENeuraxpharm Spain S.L.U.
- IrelandDolmatil 200mg TabletsNeuraxpharm Ireland Limited
- NetherlandsDogmatil 400, tabletten 400 mgNeuraxpharm Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Dogmatil, Sulpirid Grindeks
- Belgium · Dogmatil, Sulpiride Eg
- Cyprus · Devodil, Sulpiren
- Czechia · Dogmatil, Prosulpin
- Estonia · Betamaks
- Spain · Dogmatil, Dogmatil Fuerte
- Finland · Suprium
- France · Dogmatil, Dogmatil Sans Sucre, Édulcorée Au Cyclamate De Sodium
- United Kingdom (Northern Ireland) · Sulpiride, Sulpiride Activase Pharmaceuticals
- Greece · Dogmatyl
- Croatia · Eglonyl, Eglonyl Forte
- Hungary · Depral
- Ireland · Dolmatil
- Italy · Dobren
- Lithuania · Eglonyl
- Luxembourg · Dogmatil, Sulpiride Eg
- Latvia · Betamaks
- Malta · Devodil, Sulpiride Grindeks
- Netherlands · Dogmatil
- Poland · Sulpiryd Hasco, Sulpiryd Teva
- Portugal · Dogmatil, Dogmatil Forte
- Romania · Eglonyl
- Slovenia · Eglonyl
- Slovakia · Betamaks, Sulpirid Belupo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5e99a6e-1e9c-41ab-8cf1-6fcfa34d34c7 GET /v1/drugs/e5e99a6e-1e9c-41ab-8cf1-6fcfa34d34c7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Sulpiride",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about sulpiride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.